Cryolipolysis Freeze Fat With 4 Handles for OEM Companies

数据维度标题：每周会话次数与单次平均脂肪减少量（单位：cc）的时间序列比较

New Data Title: Weekly Trend of Fat Reduction per Session and Sessions Count

Explanation: This chart presents two data series over 12 consecutive weeks to examine how a four-handle cryolipolysis treatment schedule translates into weekly outcomes. The left y-axis shows Fat Reduction per Session (in cubic centimeters, cc) and the right y-axis shows the number of treatment sessions performed in a week. The x-axis tracks Weeks 1 through 12. The blue line represents the average fat reduction per session, indicating the efficiency or potency of each session. The orange line shows the number of sessions conducted weekly, reflecting utilization and capacity. Observations: The weekly sessions rise from Week 1 to Week 8, climbing from 8 to 22 sessions, suggesting ramp-up in deployment and demand. In parallel, fat reduction per session increases from roughly 18 cc to about 26 cc, indicating improving effectiveness or technique optimization. After Week 8, the sessions level off around 16–19 per week, while fat reduction per session remains in the mid-to-high 20s with a mild dip in Week 11. This pattern may reflect diminishing marginal returns as the most readily accessible fat pockets are treated early, or it could be influenced by scheduling constraints, patient mix, or operator experience. The divergence and convergence over time illustrate that more sessions do not always produce a proportional rise in per-session fat loss, and conversely, higher efficiency does not always coincide with higher weekly volume. A moderate positive relationship appears in the middle weeks, hinting at a period when training and workflow improvements maximized both throughput and per-session results. For clinicians and clinic managers, this kind of dual-axis view supports balanced decision-making: track not just total fat removal per week but also how much each session contributes on average. Real-world data would require richer covariates such as patient BMI, treatment areas, device calibration, and practitioner skill to interpret fluctuations accurately, but the dual-series chart remains a compact, intuitive tool for monitoring operational performance and clinical outcomes together.